Clinitech Laboratory
- Market cap
- ₹ 7 Cr.
- P/E
- 16.8x
- P/B
- 0.79x
- 52-week range
- 28.55 – 47.15
- ROE
- 5%
- ROCE
- 7.3%
- Dividend yield
- 0%
- Debt / equity
- 0.06
- Sector
- Healthcare Services
- Industry
- Healthcare Service Provider
- Listed on
- BSE SME
About
Clinitech Laboratory Limited is an India-based company, which is engaged in the business of providing pathology and related healthcare services. The Company is engaged in the business of healthcare services providing pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics among others. It offers test packages such as comprehensive packages, top health tests profiles, and health scans & imaging tests.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Service Provider: 36 companies →Clinitech Laboratory against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)16.8 against a typical 21: cheaper than most peers (1st = cheapest).10th of 34
- Sales growth+31.4% against a typical +19.1% from a year earlier.7th of 31
- Profit growth−60% against a typical +25.2% from a year earlier.20th of 24
- Share price, 3 months−20% against a typical −7.7%.28th of 33
- Size₹ 7.3 Cr. market value against a typical ₹ 83 Cr. (1st = largest).31st of 34
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 3 | 3 | 4 | 4 | 5 | 4 |
| Expenses | 3 | 3 | 4 | 4 | 5 | 4 |
| Operating Profit | 0 | 1 | 1 | 0 | 1 | 0 |
| OPM % | 9.2% | 21.9% | 13.7% | 6.7% | 10.6% | 10.3% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 14.3% | 30.2% | 15.4% | 41.4% | 14.3% | 52% |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS in Rs | 0.47 | 1.79 | 0.96 | 0.74 | 1.31 | 0.53 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- —
- 5 Years
- 16%
- 3 Years
- 14%
- TTM
- 15%
- 10 Years
- —
- 5 Years
- 3%
- 3 Years
- −12%
- TTM
- 40%
- 10 Years
- —
- 5 Years
- —
- 3 Years
- —
- TTM
- —
- 10 Years
- —
- 5 Years
- 10%
- 3 Years
- 6%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Clinitech Laboratory | ₹ 30.85 | ₹ 7 Cr. | 16.8x | 0.8x | 5% | — |
| Apollo Hospitals Enterprise | ₹ 7,730.00 | ₹ 1,11,146 Cr. | 57.7x | 11.9x | — | 8.1% |
| Max Healthcare Institute | ₹ 815.00 | ₹ 79,325 Cr. | 56.2x | 7.8x | — | 16.7% |
| Aster DM Healthcare | ₹ 644.75 | ₹ 56,272 Cr. | 79.9x | 7.3x | — | 7.4% |
| Fortis Healthcare | ₹ 712.90 | ₹ 53,821 Cr. | 49.9x | 5.3x | — | 11.3% |
| Global Health | ₹ 1,185.00 | ₹ 31,989 Cr. | 59.4x | 8.3x | — | 11.8% |
Management
- Jagdish Umakant Nayak
- Executive Chairman of the Board, Managing Director
- Rahul Motilal Patil
- Chief Financial Officer
- Shruti Hemant Patankar
- Company Secretary and Compliance Officer
- Jyoti Jagdish Nayak
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.